Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Smithers

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Journal of Chromatography. B, Biomedical Applications|November 17, 1995
High-performance liquid chromatographic assay for the measurement of melphalan and its hydrolysis products in perfusate and plasma and melphalan in tissues from human and rat isolated limb perfusionsZ Y Wu, M J Thompson, M S Roberts, et al.
The British Journal of Dermatology|May 13, 2021
Comparative performance of predictors of death from thin (≤ 1·0 mm) melanomaM Claeson, P Baade, M Marchetti, et al.
Gut|October 13, 2007
Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagusD C Whiteman, S Sadeghi, N Pandeya, et al.
The British Journal of Dermatology|October 14, 2020
Patient age and risk of recurrence of primary melanoma at high risk of spreadR Ghiasvand, K Khosrotehrani, M C B Hughes, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|November 3, 2019
Baseline neutrophil-lymphocyte ratio holds no prognostic value for esophageal and junctional adenocarcinoma in patients treated with neoadjuvant chemotherapyS J M van Hootegem, B M Smithers, D C Gotley, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 19, 2018
Patterns of Failure Following Dose-escalated Chemoradiotherapy for Fluorodeoxyglucose Positron Emission Tomography Staged Squamous Cell Carcinoma of the OesophagusR Effeney, T Shaw, B H Burmeister, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 26, 2019
Phenotypic and genotypic analysis of amelanotic and hypomelanotic melanoma patientsJ E Rayner, E K McMeniman, D L Duffy, et al.
The British Journal of Dermatology|March 6, 2020
Statins may reduce disease recurrence in patients with ulcerated primary melanomaL A von Schuckmann, K Khosrotehrani, R Ghiasvand, et al.
The British Journal of Surgery|February 5, 2004
Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapyW A Brown, J Thomas, D Gotley, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|October 26, 2007
Outcomes from salvage esophagectomy post definitive chemoradiotherapy compared with resection following preoperative neoadjuvant chemoradiotherapyB M Smithers, M Cullinan, J M Thomas, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Journal of Chromatography. B, Biomedical Applications|November 17, 1995
High-performance liquid chromatographic assay for the measurement of melphalan and its hydrolysis products in perfusate and plasma and melphalan in tissues from human and rat isolated limb perfusionsZ Y Wu, M J Thompson, M S Roberts, et al.
The British Journal of Dermatology|May 13, 2021
Comparative performance of predictors of death from thin (≤ 1·0 mm) melanomaM Claeson, P Baade, M Marchetti, et al.
Gut|October 13, 2007
Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagusD C Whiteman, S Sadeghi, N Pandeya, et al.
The British Journal of Dermatology|October 14, 2020
Patient age and risk of recurrence of primary melanoma at high risk of spreadR Ghiasvand, K Khosrotehrani, M C B Hughes, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|November 3, 2019
Baseline neutrophil-lymphocyte ratio holds no prognostic value for esophageal and junctional adenocarcinoma in patients treated with neoadjuvant chemotherapyS J M van Hootegem, B M Smithers, D C Gotley, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 19, 2018
Patterns of Failure Following Dose-escalated Chemoradiotherapy for Fluorodeoxyglucose Positron Emission Tomography Staged Squamous Cell Carcinoma of the OesophagusR Effeney, T Shaw, B H Burmeister, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 26, 2019
Phenotypic and genotypic analysis of amelanotic and hypomelanotic melanoma patientsJ E Rayner, E K McMeniman, D L Duffy, et al.
The British Journal of Dermatology|March 6, 2020
Statins may reduce disease recurrence in patients with ulcerated primary melanomaL A von Schuckmann, K Khosrotehrani, R Ghiasvand, et al.
The British Journal of Surgery|February 5, 2004
Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapyW A Brown, J Thomas, D Gotley, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|October 26, 2007
Outcomes from salvage esophagectomy post definitive chemoradiotherapy compared with resection following preoperative neoadjuvant chemoradiotherapyB M Smithers, M Cullinan, J M Thomas, et al.
Pageof 8